Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain
Simona Iftimie,
Ana F. López-Azcona,
María José Lozano-Olmo,
Àngels Naval-Ferrando,
Vicent Domingo-Cortés,
Helena Castañé,
Andrea Jiménez-Franco,
Anna Hernández-Aguilera,
Carmen Guilarte,
Francesc Riu,
Jordi Camps,
Jorge Joven,
Antoni Castro
Affiliations
Simona Iftimie
Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Ana F. López-Azcona
Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
María José Lozano-Olmo
Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Àngels Naval-Ferrando
Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Vicent Domingo-Cortés
Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Helena Castañé
Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Andrea Jiménez-Franco
Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Anna Hernández-Aguilera
Department of Pathology, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Carmen Guilarte
Department of Pathology, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Francesc Riu
Department of Pathology, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Jordi Camps
Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Jorge Joven
Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
Antoni Castro
Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d’Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
SARS-CoV-2 infection in already-vaccinated individuals is still possible and may require hospitalization. The aim of the present study was to evaluate the clinical evolution of patients with COVID-19 admitted to a public hospital. The outcomes were assessed in relation to the predominant viral variant and the vaccination status. This retrospective study was performed on 1295 COVID-19-positive patients who attended a 352-bed university hospital between 2021 and 2022. Clinical variables and vaccination status were recorded. Of the patients, 799 had not been vaccinated (NV, 61.7%), 449 were partially vaccinated (PV, 34.7%), and 47 were completely vaccinated (CV, 3.6%). The mean age of the CV patients was significantly higher than that of PV and NV. Additionally, they had higher percentages of chronic diseases. The outcomes depended on age but not on vaccination status. There were 209 patients admitted during the Omicron-infection period, of whom 70 (33.5%) were NV, 135 (64.6%) were PV, and 4 (1.9%) were CV. In conclusion, correct vaccination greatly reduces the risk of acquiring severe COVID-19. Partial vaccination does not guarantee protection of the population. This highlights the need for continuous vaccination promotion with all recommended doses, while also investigating alternative treatments for those patients who do not respond to the vaccines.